These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7617674)

  • 1. Asymmetrical development of the dopamine system in the fetal rat as indicated by lateralized administration of SKF-38393 and SCH-23390.
    Varlinskaya EI; Petrov ES; Robinson SR; Smotherman WP
    Pharmacol Biochem Behav; 1995 Mar; 50(3):359-67. PubMed ID: 7617674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracisternal administration of SKF-38393 and SCH-23390: behavioral effects in the rat fetus.
    Varlinskaya EI; Petrov ES; Robinson SR; Smotherman WP
    Pharmacol Biochem Behav; 1994 Jul; 48(3):741-8. PubMed ID: 7938130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal behavior and the endogenous opioid system: D1 dopamine receptor interactions with the kappa opioid system.
    Smotherman WP; Moody CA; Spear LP; Robinson SR
    Physiol Behav; 1993 Jan; 53(1):191-7. PubMed ID: 8381974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine and kappa opioid receptors on fetal responsiveness to perioral stimuli.
    Robinson SR; Moody CA; Spear LP; Smotherman WP
    Dev Psychobiol; 1993 Jan; 26(1):37-50. PubMed ID: 8382637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal behavior and the dopamine system: activity effects of D1 and D2 receptor manipulations.
    Moody CA; Robinson SR; Spear LP; Smotherman WP
    Pharmacol Biochem Behav; 1993 Apr; 44(4):843-50. PubMed ID: 8097042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
    Toyoshi T; Ukai M; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation.
    Trugman JM; James CL
    Brain Res; 1993 Apr; 607(1-2):270-4. PubMed ID: 8481802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats.
    Katz JL; Kopajtic TA; Terry P
    Behav Pharmacol; 2006 Jun; 17(4):303-9. PubMed ID: 16914948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
    Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated administration of SCH 23390 enhances the SKF 38393-induced inhibition in the rat hippocampus.
    Smiałowski A; Bijak M
    Neuroscience; 1989; 28(2):409-12. PubMed ID: 2564173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
    Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1993; 112(4):428-36. PubMed ID: 7871053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.